• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国国家抗原银行疫苗对同源 H5Nx 属 2.3.2.1 和属 2.3.4.4 高致病性禽流感病毒的保护效力。

Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.

机构信息

Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.

National Center for Veterinary Diagnostics, No. 11, 78th Lane, GiaiPhong Road, Dong Da, Hanoi, Viet Nam.

出版信息

Vaccine. 2020 Jan 16;38(3):663-672. doi: 10.1016/j.vaccine.2019.10.044. Epub 2019 Oct 25.

DOI:10.1016/j.vaccine.2019.10.044
PMID:31669062
Abstract

The occurrence of severe outbreaks of highly pathogenic avian influenza in Korea led to establishment of a national antigen bank for emergency preparedness. Here, we developed five vaccines for this bank (clade 2.3.2.1C, clade 2.3.4.4A, B, C, and D) by reverse genetics, inactivated them with formalin, and evaluated the protective efficacy and potency of serial dilutions against lethal homologous challenge in specific-pathogen-free chickens. After vaccination with one dose, each vaccine resulted in 100% survival, with no clinical symptoms, or lack of detectable virus shedding, and high levels of pre-challenge protective immunity (8.4-10.2 log). After vaccination with one-tenth of the full dose, protection was similar to that with the full dose. After vaccination with one-hundredth of the initial dose, survival was 20-80%, and all vaccines showed virus shedding. Four vaccines (excluding clade 2.3.2.1C) had satisfactory potency. In antibody-persistence tests, all vaccines maintained long-lasting protective immunity. Our results suggest that inactivated reverse-genetics vaccines genetically matched to outbreak viruses provide adequate protection after a single vaccination.

摘要

韩国高致病性禽流感的严重爆发促使建立了国家抗原库以应对紧急情况。在这里,我们通过反向遗传学为该库开发了五种疫苗(2.3.2.1C 谱系、2.3.4.4A、B、C 和 D 谱系),用福尔马林将其灭活,并评估了针对特定病原体无鸡的同源致命性挑战的连续稀释的保护效力和效力。接种一剂后,每种疫苗均能 100%存活,无临床症状或无可检测到的病毒脱落,并且具有高水平的预先挑战保护免疫力(8.4-10.2 对数)。接种十分之一的全剂量后,保护作用与全剂量相似。接种初始剂量的百分之一后,存活率为 20-80%,所有疫苗均显示出病毒脱落。四种疫苗(不包括 2.3.2.1C 谱系)具有令人满意的效力。在抗体持久性测试中,所有疫苗均保持持久的保护免疫力。我们的结果表明,与暴发病毒基因匹配的灭活反向遗传学疫苗可在单次接种后提供充分的保护。

相似文献

1
Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.韩国国家抗原银行疫苗对同源 H5Nx 属 2.3.2.1 和属 2.3.4.4 高致病性禽流感病毒的保护效力。
Vaccine. 2020 Jan 16;38(3):663-672. doi: 10.1016/j.vaccine.2019.10.044. Epub 2019 Oct 25.
2
Protection of layers and breeders against homologous or heterologous HPAIv by vaccines from Korean national antigen bank.用韩国国家抗原库的疫苗保护层和种鸡免受同源或异源 HPAIv 的侵害。
Sci Rep. 2020 Jun 10;10(1):9436. doi: 10.1038/s41598-020-66343-9.
3
Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.美国紧急使用 H5 疫苗对 2.3.4.4 分支 H5N2 高致病性禽流感病毒对怀特莱航鸡的保护。
Vaccine. 2017 Nov 1;35(46):6336-6344. doi: 10.1016/j.vaccine.2017.05.051. Epub 2017 May 26.
4
A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.两剂免疫灭活重配 H5N2 病毒可保护鸡免受同源 2.3.2.1 分支和异源 2.2 分支高致病性禽流感 H5N1 病毒的致死性挑战。
Vet Microbiol. 2018 Apr;217:149-157. doi: 10.1016/j.vetmic.2018.03.004. Epub 2018 Mar 13.
5
Protection afforded by avian influenza vaccination programmes consisting of a novel RNA particle and an inactivated avian influenza vaccine against a highly pathogenic avian influenza virus challenge in layer chickens up to 18 weeks post-vaccination.新型 RNA 颗粒和灭活禽流感疫苗组成的禽流感疫苗接种方案对 18 周龄产蛋鸡接种高致病性禽流感病毒的保护作用。
Avian Pathol. 2019 Aug;48(4):371-381. doi: 10.1080/03079457.2019.1605148. Epub 2019 May 20.
6
Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.含有不同 H5 血凝素的同源和异源抗原匹配疫苗可提供不同程度的保护,使鸡免受 2014 年美国 H5N8 和 H5N2 2.3.4.4 高致病性禽流感病毒的侵害。
Vaccine. 2017 Nov 1;35(46):6345-6353. doi: 10.1016/j.vaccine.2017.04.042. Epub 2017 Apr 26.
7
Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.一种H5N1灭活疫苗对鸡抵抗致死性H5N1、H5N2、H5N6和H5N8流感病毒攻击的保护效力
Avian Dis. 2016 May;60(1 Suppl):253-5. doi: 10.1637/11179-052015-ResNoteR.
8
Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.抗体滴度对于疫苗预防来自印度尼西亚的H5N1高致病性禽流感病毒自然抗原漂移变体攻击具有阳性预测价值。
J Virol. 2015 Apr;89(7):3746-62. doi: 10.1128/JVI.00025-15. Epub 2015 Jan 21.
9
Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.重组火鸡疱疹病毒(rHVT-H5)和灭活H5N1疫苗对商品骡鸭抵抗高致病性禽流感(HPAI)H5N1 2.2.1分支病毒的保护效力
PLoS One. 2016 Jun 15;11(6):e0156747. doi: 10.1371/journal.pone.0156747. eCollection 2016.
10
Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam.H5 灭活疫苗对在中国和越南分离出的不同高致病性 H5N1 禽流感病毒的保护效力。
Avian Dis. 2010 Mar;54(1 Suppl):287-9. doi: 10.1637/8707-031709-ResNote.1.

引用本文的文献

1
Avian Influenza Clade 2.3.4.4b: Global Impact and Summary Analysis of Vaccine Trials.禽流感2.3.4.4b分支:全球影响及疫苗试验综述分析
Vaccines (Basel). 2025 Apr 24;13(5):453. doi: 10.3390/vaccines13050453.
2
Statistical Analysis of the Performance of Local Veterinary Laboratories in Molecular Detection (rRT-PCR) of Avian Influenza Virus via National Proficiency Testing Performed during 2020-2022.2020-2022 年期间通过国家能力验证对地方兽医实验室进行的禽流感病毒分子检测(rRT-PCR)性能的统计分析。
Viruses. 2023 Mar 24;15(4):823. doi: 10.3390/v15040823.
3
Updating the National Antigen Bank in Korea: Protective Efficacy of Synthetic Vaccine Candidates against H5Nx Highly Pathogenic Avian Influenza Viruses Belonging to Clades 2.3.2.1 and 2.3.4.4.
更新韩国国家抗原库:合成候选疫苗对属于2.3.2.1和2.3.4.4分支的H5Nx高致病性禽流感病毒的保护效力
Vaccines (Basel). 2022 Nov 3;10(11):1860. doi: 10.3390/vaccines10111860.
4
Live Recombinant NDV-Vectored H5 Vaccine Protects Chickens and Domestic Ducks From Lethal Infection of the Highly Pathogenic H5N6 Avian Influenza Virus.活重组新城疫病毒载体H5疫苗可保护鸡和家鸭免受高致病性H5N6禽流感病毒的致死性感染。
Front Vet Sci. 2022 Feb 3;8:773715. doi: 10.3389/fvets.2021.773715. eCollection 2021.
5
Single dose of multi-clade virus-like particle vaccine protects chickens against clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.单剂量多分支病毒样颗粒疫苗可保护鸡免受 2.3.2.1 分支和 2.3.4.4 高致病性禽流感病毒的侵害。
Sci Rep. 2021 Jul 2;11(1):13786. doi: 10.1038/s41598-021-93060-8.